Get the Stockscreener App
6.82
9.55%
-0.72
Treace Medical Concepts Inc stock is traded at $6.82, with a volume of 2.35M.
It is down -9.55% in the last 24 hours and down -7.96% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$7.54
Open:
$6.8
24h Volume:
2.35M
Relative Volume:
5.73
Market Cap:
$452.92M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.6719
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-6.06%
1M Performance:
-7.96%
6M Performance:
-15.17%
1Y Performance:
+53.95%
1-Day Range:
$5.895
$7.00
1-Week Range:
$5.895
$7.73
52-Week Range:
$4.2949
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.82 | 452.92M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Stifel Financial Corp Buys 55,540 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Raymond James Financial Inc. Invests $392,000 in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts’ Earnings Call: Balancing Growth and Challenges - TipRanks
UBS Adjusts Price Target on Treace Medical Concepts to $8.60 From $10, Maintains Neutral Rating - marketscreener.com
Scott+Scott Attorneys at Law LLP Reminds Investors of the - GlobeNewswire
2025-05-09 | TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:TMCI | Press Release - Stockhouse
Treace Medical Concepts, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your RightsTMCI - Morningstar
Treace Medical Concepts: Q1 Earnings Snapshot - New Haven Register
Investors who lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class ActionTMCI - ACCESS Newswire
Treace Medical Concepts Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Treace Medical Concepts Reports First Quarter 2025 Financial Results - The Manila Times
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & ... - Bluefield Daily Telegraph
Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class ActionTMCI - ACCESS Newswire
The Gross Law Firm Notifies Shareholders of Treace Medical Concepts, Inc.(TMCI) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Treace Medical Concepts Reports Q1 2025 Financial Results - TipRanks
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc. (TMCI) - ACCESS Newswire
TMCI Investors Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit - PR Newswire
Treace Medical Concepts, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross ... - Eagle-Tribune
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - The Malaysian Reserve
What To Expect From Treace Medical Concepts Inc (TMCI) Q1 2025 Earnings - GuruFocus
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025TMCI - ACCESS Newswire
Treace Medical Concepts, Inc. Investors: Please contact the - GlobeNewswire
Treace Medical Concepts, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 10, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire Inc.
Treace Medical Concepts Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Deadline Alert: Treace Medical Concepts, Inc. (TMCI) - GlobeNewswire
Scott+Scott Attorneys at Law LLP Alerts Investors an Action - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Treace Medical Concepts, Inc. (TMCI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - StreetInsider
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming DeadlinesTMCI - PR Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Marshall Wace LLP - MarketBeat
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure ... - Eagle-Tribune
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class ... - Eagle-Tribune
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A - GlobeNewswire
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - FinancialContent
PDT Partners LLC Has $217,000 Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Renaissance Technologies LLC Acquires 76,700 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionTMCI - ACCESS Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - StreetInsider
137,744 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Susquehanna Fundamental Investments LLC - MarketBeat
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - MarketBeat
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to - Bluefield Daily Telegraph
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a - Bluefield Daily Telegraph
Press Release Distribution & PR Platform - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against Treace Medical Concepts, Inc.(TMCI) - PR Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Holdings Boosted by Renaissance Technologies LLC - Defense World
Legal & General Group Plc Decreases Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):